Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Open: 20.59 Close: 20.81 Change: 0.22
The game is changing. There is a new strategy to evaluate Akero Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Akero Therapeutics are: Akero, Therapeutics, price, loss, beta, indicate, share, …
Akero Therapeutics, Inc. engages in the development of transformational treatments for patients with serious metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc..
Akero Therapeutics has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Kamada has higher revenue and earnings than Akero. Akero Therapeutics Inc. - 54.12% loss is 10.17% loss. Akro: akero therapeutics inc stock price quote - 20.81 Arrow Down –0.17 – 0.81 %.
Akero Therapeutics has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Kamada has higher revenue and earnings than Akero. Akero Therapeutics Inc. - 54.12% loss is 10.17% loss. Akro: akero therapeutics inc stock price quote - 20.81 Arrow Down –0.17 – 0.81 %.
"Akero Therapeutics, Inc., a clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company is also conducting a Phase 2b clinical trial to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California."
How much time have you spent trying to decide whether investing in Akero Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Akero Therapeutics are: Akero, Therapeutics, price, loss, beta, indicate, share, and the most common words in the summary are: acquire, therapeutic, website, pharmaceutical, go, rename, dec, . One of the sentences in the summary was: - 54.12% loss is 10.17% loss. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #acquire #therapeutic #website #pharmaceutical #go #rename #dec.
Read more →Open: 20.59 Close: 20.81 Change: 0.22
Read more →Open: 14.5 Close: 15.62 Change: 1.12
Read more →Open: 45.62 Close: 44.34 Change: -1.28
Read more →Open: 22.11 Close: 23.57 Change: 1.46
Read more →Open: 52.07 Close: 53.24 Change: 1.17
Read more →